A complete endovascular revascularisation of atherothrombotic occlusion of popliteal artery and below-the-knee arteries in a polymorbid patient – a case report

Czech version

Authors: M. Válka ¹; L. Puszkailer ²; D. Kučera ^1,3; J. Bezecný ¹; J. Kozák ¹; D. Maděřič ¹; J. Krátký ¹; V. Jetmar ¹; D. Boháčová ⁴
Authors‘ workplace: Vaskulární centrum, Vítkovická nemocnice a. s., Ostrava ¹; Chirurgicko-traumatologické oddělení, Středomoravská nemocniční a. s. – Nemocnice Šternberk ²; II. interní klinika kardiologie a angiologie 1. LF UK a VFN v Praze 4 Angiologie Opava s. r. o. ³
Published in: Kardiol Rev Int Med 2016, 18(3): 191-194

Overview

We present a complete endovascular revascularisation of an atherothrombotic occlusion of the popliteal artery (APo) and below-the-knee arteries in a polymorbid patient, using several endovascular techniques, specifically local continual pharmacological thrombolysis, mechanical thrombectomy (Rotarex), aspiration thrombectomy and PTA of the below-the-knee arteries with stent deployment.

Keywords:
local thrombolysis –⁠ drug-coated balloon angioplasty –⁠ drug-eluting stenting

Sources

1. Schmidt A, Piorkowski M, Görner H et al. Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry. JACC Cardiovasc Interv 2016; 9 : 715–724. doi: 10.1016/j.jcin.2015.12.267.

2. Jaff MR, Rosenfield K, Scheinert D et al. Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial. Am Heart J 2015; 169 : 479–485. doi: 10.1016/j.ahj.2014.11.016.

3. Mosquera Arochena NJ. Drug eluting stents remain the golden standard for below-the-knee occlusive disease. J Cardiovasc Surg (Torino) 2016; 57 : 677–682.